Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

http://www.businesswire.com/news/home/20110328005958/en/Medtronic-Unveil-Pivotal-U.S.-Data-Resolute%C2%AE-Drug-Eluting

Medtronic, Inc.announced the imminent release of the pivotal U.S. data on its Resolute^® drug-eluting stent (DES) at ACC.11, the 60^th Annual Scientific Session & Expo of the American College of Cardiology, which takes place April 2–5 in New Orleans.

“Two-Year Outcomes from the Randomized RESOLUTE All-Comers Trial”

The one-year results of the study, called RESOLUTE US, will be presented in the late-breaking clinical trials session for interventional cardiology on Monday, April 4. These new data complete Medtronic’s submission to the U.S. Food and Drug Administration (FDA) for pre-market approval of the Resolute DES, which remains investigational in the United States.